Doxazocin
Doxazocin
In the dynamic landscape of pharmaceuticals and chemicals, ensuring the highest standards of quality control is paramount. This forum serves as a platform for professionals, experts, and enthusiasts alike to engage in meaningful discussions, share insights, and exchange best practices in quality control processes.
In order to meet the expenses associated with maintaining and improving the forum, we have made the decision to introduce paid subscriptions for access to select sections of the Quality Control forum. These sections will offer premium content, SOP's,MSDS's, exclusive resources, and specialized discussions curated to meet the diverse needs and interests of our members. With a focus on enhancing product quality, ensuring regulatory compliance, and fostering innovation, this forum covers a diverse range of topics relevant to the pharmaceutical and chemical industries. Some of the key areas of discussion include:
- Raw Material Testing
- In-process Testing
- Finished Product Testing
- Stability Testing/Studies
- Environmental Monitoring
- This topic has 0 replies, 1 voice, and was last updated 2 years ago by
.
Viewing 1 post (of 1 total)
-
1. Doxazocin:
INTRODUCTION:
Doxazosin Mesylate is a quinazoline compound that is a selective inhibitor of the alpha1 subtype of alpha-adrenergic receptors. Doxazosin mesylate is freely soluble in dimethylsulfoxide, soluble in dimethylformamide, slightly soluble in methanol, ethanol, and water (0.8% at 25°C), and very slightly soluble in acetone and methylene chloride.
Doxacard-2 Tablets are quiniline yellow WS coloured, uncoated and round shaped tablets.-
This topic was modified 2 years ago by
-
This topic was modified 2 years ago by
Viewing 1 post (of 1 total)
- You must be logged in to reply to this topic.